NASDAQ: WENAAnew Medical Inc Stock
$0.73-0.08 (-9.88%)
Updated Sep 6, 2024
Shares of companies within the... find out Why WENA Price Moved with a free WallStreetZen account
Why Price MovedWENA Price
$0.73
Fair Value Price
-$0.15
Market Cap
$12.58M
52 Week Low
$0.72
52 Week High
$13.10
P/E
N/A
P/B
-8.11x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$2.80M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-3.13
Operating Cash Flow
-$514k
Beta
0.22
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
WENA Overview
Redwoods Acquisition Corporation is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or other similar combinations with one or more businesses. In intends to target the carbon neutral and energy storage industries. Redwoods Acquisition was incorporated in 2021 and is headquartered in New York, NY.
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how WENA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WENA ($0.73) is overvalued by 597.13% relative to our estimate of its Fair Value price of -$0.15 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
WENA ($0.73) is not significantly undervalued (597.13%) relative to our estimate of its Fair Value price of -$0.15 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
WENA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more WENA due diligence checks available for Premium users.
Be the first to know about important WENA news, forecast changes, insider trades & much more!
WENA News
Valuation
WENA fair value
Fair Value of WENA stock based on Discounted Cash Flow (DCF)
Price
$0.73
Fair Value
-$0.15
Undervalued by
597.13%
WENA ($0.73) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
WENA ($0.73) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
WENA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
-46.85x
Market
24.57x
WENA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-8.11x
Industry
6.22x
WENA's financial health
Profit margin
Revenue
$0.0
Net Income
-$451.6k
Profit Margin
0%
WENA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$3.3M
Liabilities
$4.9M
Debt to equity
-3.13
WENA's short-term assets ($999.84k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WENA's long-term liabilities ($3.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WENA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
WENA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$907.4k
Investing
-$1.0
Financing
$1.7M
WENA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
WENA vs Biotech Stocks
Anew Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.